AKT1 and neoplasm: In summary, this study suggests that CLEC19A overexpression reduces tumor cell proliferation and migration by suppressing PI3K/AKT/NF-κB and VEGF/MMPs signaling pathways and promotes cell apoptosis and arrested cells in the sub-G1 phase in U87 and C6 cell lines (Fig. 7).